Global Medical Elastomers Market 2018-2022: Key Players are BASF SE, DowDuPont, Eastman Chemical Company, Royal DSM & and Solvay S.A

News provided by

May 23, 2018, 05:15 ET

DUBLIN, May 23, 2018 /PRNewswire/ --

The "Medical Elastomers Market by Type (Thermoset and Thermoplastic), Application (Medical Tubes, Catheters, Syringes, Gloves, Medical Bags, and Implants), and Region (North America, Europe, APAC, MEA, and South America) Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The medical elastomers market is projected to grow from USD 5.51 Billion in 2017 to USD 7.92 Billion by 2022, at a CAGR of 7.5% during the forecast period from 2017 to 2022.

The growth of the market is attributed to the rising demand for medical devices across the globe. Increased awareness among governments to provide high-quality healthcare infrastructure is expected to drive the demand for medical devices, which will, in turn, lead to the growth of the medical elastomers market across the globe. Also, technological advancement in the thermoplastic elastomer processing industry has made these elastomers an ideal choice for medical device manufacturing, leading to an increase in demand for thermoplastic medical elastomers in medical devices.

Based on type, the medical elastomers market has been segmented into thermoplastic and thermoset elastomers. The thermoplastic elastomers segment accounted for a larger share of the medical elastomers market in 2017. This segment is also projected to grow at a higher CAGR than the thermoset segment during the forecast period. The growth of thermoplastic elastomers is attributed to their increased demand in the manufacturing of medical tubes, catheters, medical bags, and other devices.

Based on application, the medical elastomers market has been segmented into medical tubes, catheters, syringes, gloves, medical bags, implants, and others. The medical tubes segment accounted for the largest market share in 2017. The increasing use of medical tubes in the diagnosis and treatment of diseases is further expected to drive the market for medical elastomers. The implants application segment is projected to grow at the highest CAGR during the forecast period owing to the increasing demand for orthopedic and prosthetic implants.

The medical elastomers market has been studied for APAC, North America, Europe, South America, and the Middle East & Africa. The APAC region is expected to lead the medical elastomers market during the forecast period. The growth of the APAC medical elastomers market is attributed to the region's growing population and increasing healthcare expenditure of various countries, such as India, Indonesia, and China.

Additionally, increased investments from private and government sectors to improve the healthcare infrastructure across countries are also expected to create a demand for medical devices, thereby fueling the growth of the medical elastomers market in the region. The medical elastomers market is witnessing significant growth in China, India, Indonesia, and Saudi Arabia, owing to the increased consumption of medical devices in these countries.

Some of the key players operating in the medical elastomers market include BASF SE (Germany), DowDuPont (US), Eastman Chemical Company (US), Royal DSM (Netherlands), and Solvay S.A. (Belgium).

For instance, in 2017, Royal DSM (Netherlands) formed a partnership with the Musculoskeletal Transplant Foundation (MTF), a non-profit organization based in the US. This partnership is expected to help the company fulfill the changing requirements of reconstructive surgeries, along with material requirements in implants application. It will also help the company identify new opportunities in the medical & pharmaceutical industry. Dow (US) and DuPont (US) also announced their merger of equals in 2017.

The newly formed company operates under the name DowDuPont. This merger enabled the companies to use each other's resources and to increase their effectiveness in the core markets.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Significant Opportunities in The Medical Elastomers Market
4.2 Medical Elastomers Market By Application
4.3 Medical Elastomers Market in APAC, By Country and Application
4.4 Medical Elastomers Market Size, By Type

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advancements in Thermoplastic Elastomer Processing Industry Increasing The Demand for Medical Elastomers
5.2.1.2 Increasing Demand for Medical Devices That Incorporate Medical Elastomers
5.2.1.3 Growing Awareness and Government Initiatives to Provide High-Quality Healthcare Facilities
5.2.2 Restraints
5.2.2.1 Significant Investment and Time Required for Product Development
5.2.3 Opportunities
5.2.3.1 Growing Healthcare Investment in Emerging Economies
5.2.3.2 Replacement of Metals With Plastics
5.2.4 Challenges
5.2.4.1 Stringent Regulatory Policies
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of Substitutes
5.3.4 Threat of New Entrants
5.3.5 Intensity of Competitive Rivalry

6 Medical Elastomers Market, By Type
6.1 Introduction
6.2 Thermoset Elastomers
6.2.1 Silicone
6.2.1.1 Liquid Silicone Rubber (LSR)
6.2.1.2 High Consistency Rubber (HCR)
6.2.2 Others
6.3 Thermoplastic Elastomers
6.3.1 Thermoplastic Polyurethane (TPU)
6.3.2 Styrene Block Copolymers (SBC)
6.3.3 Others

7 Medical Elastomers Market, By Application
7.1 Introduction
7.2 Medical Tubes
7.3 Catheters
7.4 Gloves
7.5 Syringes
7.6 Medical Bags
7.7 Implants
7.8 Others

8 Medical Elastomers Market, By Region
8.1 Introductions
8.2 North America
8.2.1 Us
8.2.2 Mexico
8.2.3 Canada
8.3 APAC
8.3.1 China
8.3.2 India
8.3.3 South Korea
8.3.4 Japan
8.3.5 Indonesia
8.3.6 Rest of APAC
8.4 Europe
8.4.1 Germany
8.4.2 Italy
8.4.3 UK
8.4.4 France
8.4.5 Rest of Europe
8.5 Middle East & Africa
8.5.1 Saudi Arabia
8.5.2 South Africa
8.5.3 Egypt
8.5.4 Rest of Middle East & Africa
8.6 South America
8.6.1 Brazil
8.6.2 Rest of South America

9 Competitive Landscape
9.1 Overview
9.2 Market Ranking
9.3 Competitive Situation & Trends
9.3.1 Expansions, 2015-2017
9.3.2 Mergers, Joint Ventures, Partnerships, and Acquisitions, 2015 - 2017
9.3.3 New Product Launches, 2015-2017

10 Company Profile
10.1 BASF SE
10.2 Dowdupont
10.3 Solvay S.A.
10.4 Royal DSM
10.5 Eastman Chemical Company
10.6 Trelleborg AB
10.7 Kuraray Co., Ltd.
10.8 Teknor Apex
10.9 Momentive Performance Materials Inc.
10.10 Celanese Corporation
10.11 Polyone Corporation
10.12 Other Companies
10.12.1 Kraton Corporation
10.12.2 Raumedic AG
10.12.3 Hexpol AB
10.12.4 Foster Corporation
10.12.5 RTP Company
10.12.6 the Hygenic Corporation
10.12.7 Biomerics

For more information about this report visit https://www.researchandmarkets.com/research/s5mf2k/global_medical?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets